Bristol-Myers Squibb Company (
) will begin trading ex-dividend on December 31, 2013. A cash
dividend payment of $0.36 per share is scheduled to be paid on
February 03, 2014. Shareholders who purchased BMY stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an 2.86% increase over the prior quarter. At the
current stock price of $53.15, the dividend yield is 2.71%.
The previous trading day's last sale of BMY was $53.15,
representing a -2.46% decrease from the 52 week high of $54.49 and
a 66.77% increase over the 52 week low of $31.87.
BMY is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). BMY's current earnings per share, an indicator of a company's
profitability, is $1.67. Zacks Investment Research reports BMY's
forecasted earnings growth in 2013 as -12.63%, compared to an
industry average of -2.9%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to BMY through an Exchange
Traded Fund [ETF]?
The following ETF(s) have BMY as a top-10 holding:
- iShares U.S. Pharmaceutical ETF (
- PowerShares Dynamic Pharmaceuticals (
- Merrill Lynch Pharmaceutical HOLDRS (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
The top-performing ETF of this group is PJP with an increase of
14.13% over the last 100 days. IHE has the highest percent
weighting of BMY at 7.39%.